For decades, scientists have searched for a way to outsmart Lyme disease, a stealthy infection that affects nearly half a million people each year in the U.S. Now, a breakthrough may be within reach.

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

In the realm of Lyme disease research, one antibiotic emerged as being highly effective for treatment of acute infection, and ...

Other pre-emptive steps are being taken by scientists to prevent Lyme disease, including the development of a vaccine. Vaccines has been developed throughout the centuries. It is derived from the ...

This cat vaccine market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market ...

Get Instant Summarized Text (Gist) A new approach to Lyme disease vaccine development focuses on the bacterial protein CspZ, which helps the bacteria evade the immune system. By engineering CspZ ...

Lyme disease infects about 476,000 people in the United States each year and can lead to severe complications such as ongoing fatigue and joint issues. However, no human vaccine is yet ...

Just in time for tick season, new research is shining a light on how animals develop resistance to tick bites, which points ...

Piperacillin, an antibiotic in the same class as penicillin, effectively cured mice of Lyme disease at 100-times less than the effective dose of doxycycline, the current gold standard treatment. At ...

Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects about 476,000 people in the U.S. each year and can come with severe complications such ...

According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.